CSI Market
Sign In | Register

Roivant Sciences Ltd (ROIV) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ROIV Annual Cash Flow →
The data below summarizes Roivant Sciences Ltd's cash flow activity from Mar 31 2025 to Mar 31 2026, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
12 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-397.91
Depreciation & amortization3.35
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation346.17
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Gain Loss On Fair Value Of Debt And Liability Instruments47.70
Gain Or Loss On Deconsolidation Of Subsidiary-
Gain On Termination Of Equity Interest Options-
Operating Lease Right Of Use Asset Amortization Expense6.41
Gain Loss On Recovery Of Contingent Consideration Discontinued Operations-
Increase Decrease In Litigation Settlement Receivables-0.35
Increase Decrease In Operating Lease Liability-
Income taxes85.05
Gain (Loss) on Investments-105.05
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable, Trade3.42
Increase (Decrease) in Accrued Liabilities59.33
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital3.04
Other Noncash Income (Expense)1.83
Other net0.00
Payments for (Proceeds from) Other Operating Activities-32.92
Discontinued operations0.00
Net Cash flow from Operating Activities-750.35
Investing Activities
Capital Expenditures-8.21
Sale of Capital Items0.00
Short-term Investments Proceeds3,307.30
Payments to Acquire Available-for-sale Securities, Debt-4,795.86
Real Estate Investments0.00
Payments To Acquire Investments In Unconsolidated Entities-
Increase Decrease In Other Investing Net-
Milestone Payments-
Proceeds From Sale Of Assets-
Proceeds From Maturity Of Marketable Securities2,745.00
Proceeds From Sale Of Marketable Securities Available For Sale200.77
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Divestiture of Interest in Consolidated Subsidiaries0.00
Cash Divested from Deconsolidation-4.42
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-2.52
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-682.33
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-48.60
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net221.85
Proceeds From Issuance Of Subsidiary Common Shares Net-
Proceeds From Subsidiary Debt Financings Net-
Repayment Of Long Term Debt And Convertible Debt By Subsidiary-
Payment For Debt Maintenance Fee By Subsidiary-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Subscription Receivable Related To Issuance Of Subsidiary Common Shares-
Other Non Cash Transactions-
Payments Of Taxes For The Repurchase Of Equity-39.87
Finance Lease Principal Payments-
Payment For Warrant Redemptions-
Issuance Of Subsidiary Shares In Connection With Debt Renegotiation-
Operating Lease Right Of Use Assets Obtained And Exchanged For Operating Lease Liabilities9.14
Common Shares And Other Consideration Issued For Purchase Of Property And Equipment-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities134.24
Effect of exchange rate on cash flow3.77
Discontinued operations0.00
Free Cash Flow-758.56
Total Cash Flow-1,294.68
4 historic quarters locked

Sign in to unlock the full Roivant Sciences Ltd cash flow history.

Sign In Create Free Account

About Roivant Sciences Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001635088-26-000090

Figures are derived from filed reports and may be restated. Historical data is subject to revision.